Efficacy and safety of rechallenge [177Lu]Lu-PSMA-617 RLT after initial partial remission in patients with mCRPC: evaluation of a prospective registry (REALITY study)

Genitourinary CancerNuclear Medicine
Do you want to read an article? Please log in or register.